Equibles does not estimate personal net worth.
Get an email with a short summary when Sana Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get SANA alertsSteve Harr is recorded as CEO at Sana Biotechnology, Inc. (SANA). Steve Harr has spoken on 3 investor events across 1 company, most recently for Sana Biotechnology, Inc. on September 14, 2026. Sana Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sana Biotechnology, Inc. includes Brian Piper (CFO), Steven D. Harr (CFO), Steven D. Harr, M.D. (CFO and Board Member) and 5 others.
“I'm sure everybody here recognizes we'll make forward-looking statements, and like you, I have my own little risk factor. Please read our 10-Q for looking at those risk factors.”
“Well, first of all, Salveen, thank you, and thank you, Goldman Sachs, for having us, and thank you for everybody in the room and online who are joining us. Yeah, so maybe just one last thing I'd say.”
“I'll start, since you asked me, to look at the year ahead of us by making sure everybody knows we'll make forward-looking statements. So, you know, take a look at our disclosures, read about our risk factors.”
Biotechnology · Healthcare
CEO
